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dependence on the egg supply and provide greater produc-
tion ﬂexibility.
doi:10.1016/j.ijid.2010.02.1508
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Emerging Trends: Vaccines in late development
R.L. Atmar
Baylor College of Medicine, Houston, TX, USA
A number of strategies are being pursued to increase the
availability of and to improve the immunogenicity, efﬁcacy,
and effectiveness of seasonal inﬂuenza vaccines. Many of
these approaches have led to vaccine candidates that are
in the late stages of clinical evaluation (i.e., Phase 3 trials)
or that have been recently licensed. Approaches to increase
the availability of inﬂuenza vaccines in the United States
include the licensure of vaccines approved in other countries
and the production of inﬂuenza virus antigens by cell cul-
ture (eg, canine kidney cells and Vero cells) rather than by
growth in embryonated eggs. Some cell culture-derived vac-
cines are approved in Europe. The inﬂuenza hemagglutinin is
partially puriﬁed from whole virus in currently licensed vac-
cines. Another approach is the production of inﬂuenza virus
hemagglutinin with a baculovirus expression system. Alter-
native routes of immunization have also been explored, and
an intradermally administered vaccine has recently been
approved for use in persons 60 years of age and older in
Europe. Improved vaccine immunogenicity and efﬁcacy may
be attained through the use of adjuvants or higher doses
of hemagglutinin. Although several adjuvanted inﬂuenza
virus vaccines are approved in other countries, none are
licensed in the United States. However, oil-in-water adju-
vants are in advanced stages of evaluation. A high-dose (60
mcg hemagglutinin) trivalent inﬂuenza vaccine has recently
been licensed based upon its superior immunogenicity com-
pared with the standard dose (15 mcg hemagglutinin), to be
used in persons 65 years of age and older. Phase 4 studies of
the high-dose vaccine are under way to determine whether
the improved immunogenicity is associated with increased
vaccine efﬁcacy and effectiveness.
doi:10.1016/j.ijid.2010.02.1509
Traveler’s diarrhea and enteric diseases of Latin
America (Invited Presentation)
12.001
Epidemiology of Traveler’s Diarrhea
A. McCarthy
Ottawa Hospital, Ottawa, ON, Canada
This presentation will provide a review of etiologies and
risk factors for diarrhea in those visiting Latin America and
will provide some comparison with travelers to other desti-
nations.
doi:10.1016/j.ijid.2010.02.1510
e
s
s
i
g
A
cts e13
2.002
raveler’s Diarrhea: Prevention and Treatment
. Steffen
University of Zurich, Zurich, Switzerland
Different options for the prevention of travelers’ diarrhea
TD) exist. Risk reduction is possible by implementing the
azard Analysis Critical Control Point System or by improve-
ent of the local infrastructure. To abandon travel plans
r to abstain from potentially contaminated food and bev-
rages is not attractive. Both a cholera and a candidate
T-ETEC transcutaneous patch vaccine have been shown to
revent TD by LT-ETEC strains, possibly by other pathogens.
mong drugs suggested for chemoprophylaxis, probiotics
howed at best a low protective efﬁcacy rate; bismuth sub-
alicylate was modestly effective. Many older antibacterial
gents are obsolete because of antimicrobial resistance by
revalent enteric bacterial pathogens. The fear of systemic
eactions has limited the prescription of ﬂuoroquinolones.
oorly absorbed antibiotics, mainly rifaximin, are more
ttractive for compliant travelers.
As no current prophylactic measure is satisfactory, (self)-
herapy of TD remains an important option (travel kit!). Only
ew still recommend to wait for spontaneous cure; rapid
elief is often important as incapacitation and the necessity
o change travel plans have a great impact. Probiotics and
harcoal have been demonstrated to offer no clinically rel-
vant beneﬁt. Oral rehydration solutions have no effect on
he duration or amount of diarrhea, but they are essential in
aediatric patients and senior travelers. Antimotility agents
ffer fast relief, but they are contraindicated in dysentery,
lso they are often followed by a period of constipation.
Antimicrobial agents, mainly quinolones and particularly
n SE-Asia also azithromycin, have been used in this decade,
lthough there is only limited recent data on the frequency
f resistance from analysis of TD stool samples on all con-
inents. The non-absorbed rifamycin-derivative rifaximin —
ith a broad antimicrobial spectrum and a tolerance pro-
le similar to placebo — has been demonstrated in patients
ith TD to be as effective as ciproﬂoxacine, but this only in
on-invasive cases of TD.
oi:10.1016/j.ijid.2010.02.1511
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elminths of Latin America
. Coyle
Albert Einstein College of Medicine, Bronx, NY, USA
This session will focus on intestinal helminths. Ascaris
umbricoides is among the most prevalent of parasitic
nfections in humans. Most patients are asymptomatic or
xperience mild abdominal pain. Children have the high-
st intensity of infections and generally present with more
evere clinical manifestations. The most common clinical
yndromes of ascariasis are pneumonitis, intestinal, bil-
ary and pancreatic obstruction. Ascariasis adversely affects
rowth, development, and nutritional status of children.
nother helminth, Hookworm, is particularly troubling for
hildren and women of reproductive age who are vulnerable
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o the effects of hookworm anemia. Trichuris is an important
elminth in which most cases of are asymptomatic. Heavy
nfections can result in the Trichuris dysentery syndrome
TDS). This syndrome includes chronic dysentery, rectal pro-
apse, anaemia, poor growth, and clubbing of the ﬁngers.
he severe stunting in TDS now appears likely to be a reac-
ion at least in part to a chronic inﬂammatory response and
oncomitant decreases in plasma insulin, plasma insulin-
ike growth factor-1 (IGF-1), increases in tumor necrosis
actor-(TNF-) in the lamina propria of the colonic mucosa
nd peripheral blood (which likely decreases appetite and
ntake of all nutrients) and a decrease in collagen synthe-
is. Improvements in cognitive performance have been found
fter treatment for relatively heavy infections in school
ge children. Synergistic associations between hookworm
nd other helminths has been described. In a recent study
rom Brazil, 61% of individuals harbored mixed helminth
nfections. Multivariate analysis indicated signiﬁcant pos-
tive associations for co-infection with hookworm and S.
ansoni and for co-infection with hookworm and A. lum-
ricoides. Co-infection with hookworm and Ascaris resulted
n higher egg counts for both, suggesting a synergistic rela-
ionship between these species, although, the intensity of
. mansoni or A. lumbricoides co-infection did not differ
rom that of mono-infection. Another study from from Brazil
ooking at Hookworm and Ascaris infection and the impact
f polyparasitism on cognitive performance in Brazilian
choolchildren suggested that hookworm may be associated
ith poorer concentration and information processing skills
hile A. lumbricoides infection may be associated with
oorer general intelligence. Polyparasitized children seem
o experience worse outcomes that children with only one
elminth infection. In yet another study, multivariate anal-
sis revealed that stunting was signiﬁcantly associated with
scaris infection among children and adolescents, whereas
ow body mass was signiﬁcantly associated with hookworm
nfection among adults and the elderly.
Strongyloides stercoralis can cause acute infection,
hronic infection and hyperinfection syndrome. Hyperinfec-
ion syndrome has been associated with a variety of risk
actors and predisposing conditions, including new immuno-
uppressive therapy therapies; HTLV-1 infection; cadaveric
ransplantation; immune reconstitution syndrome; hema-
ological malignancies (especially lymphoma). Co-infection
ith with HTLV-1 results in decreases in IL-5, and parasite
peciﬁc IgE responses in patients with strongyloidiasis con-
istent with a relative switch from Th1 to Th2 response
eading to an increased risk of autoinfection resulting in
yperinfection syndrome. Co-infected patients with HTLV-1
nd strongyloides may not respond as well to anti-helminth
reatment. In addition to HTLV-1, corticosteroid use remains
ne of the most frequent risk factors for hyperinfection
yndrome. Hyperinfection syndrome presents with diverse
ymptoms and signs often leading to misdiagnosis on the
linicians part. It is associated with a high mortality rate
15-87%). Therefore, increased recognition is important for
linicians caring for at-risk patients.Of the ﬁve major species of Schistosomiasis pathogenic
o humans the only one endemic in South America is Schisto-
oma mansoni. Despite the efforts in carrying out integrated
ontrol programs during the last 25 years, there are still
egions where the prevalence of S. mansoni is over 50%.
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eavily infected, susceptible individuals are at risk for
eveloping hepatosplenic disease. Pulmonary involvement
n S. mansoni is reported in acute schistosomiasis and in
hronic disease. Recent studies from Brazil suggest that pul-
onary hypertension may be more common than previously
hought in individuals with hepatosplenic disease due to S.
ansoni. Similarly, recent studies suggest that hepatopul-
onary syndrome also occurs in patients with S. mansoni
ho also have periportal ﬁbrosis and portal hypertension.
lthough CNS involvement is rare, it is well described. Trans-
erse myelitis or seizures have been described in both acute
nd chronic infection.
oi:10.1016/j.ijid.2010.02.1512
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ood-borne Toxins
. Ansdell
Kaiser Honolulu Clinic, Tropical and Travel Medicine, Hon-
lulu, HI, USA
Food-borne toxins are an important cause of morbidity
n the unwary traveler. In rare situations, deaths may occur.
ducation is the key to prevention and a careful history is
sually the key to diagnosis.
Ingestion of contaminated ﬁsh and shellﬁsh is one of the
ommonest causes of poisoning and the risk from marine
oxins appears to be increasing as a result of multiple fac-
ors such as global warming, coral reef damage and spread
f toxic algal blooms. Important examples include ciguatera
oisoning from ingestion of large carnivorous coral reef ﬁsh,
uffer ﬁsh poisoning and various shellﬁsh poisonings such as
aralytic shellﬁsh poisoning. Scombroid poisoning occurs in
pen ocean ﬁsh such as tuna and mahi mahi that contain his-
idine in the ﬂesh. Inadequate chilling after capture results
n conversion of histidine to histamine and symptoms that
esemble an acute allergic reaction.
In most cases the presence of toxin does not affect the
ppearance, smell or taste of seafood and it is not destroyed
y cooking, smoking, freezing or drying. Onset of illness typ-
cally occurs soon after ingestion of contaminated food and
roduces gastrointestinal symptoms such as diarrhea, nau-
ea, vomiting and abdominal pain often followed by a variety
f neurological and cardio respiratory symptoms. Paradoxi-
al dysesthesiae such as temperature reversal (hot objects
eel cold and cold objects feel hot) are very characteristic
f ciguatera and neurotoxic shellﬁsh poisoning.
Treatment is usually symptomatic and supportive. In the
ase of scombroid poisoning antihistamines provide speciﬁc
reatment and in the case of ciguatera poisoning intravenous
annitol may reduce the severity and duration of some of
he neurological features. Diagnosis is usually based on a
areful history. Test kits that detect ciguatoxin in contami-
ated ﬁsh are commercially available.
Ackee poisoning and cassava poisoning are examples of
ood poisoning from non-marine sources. Ackee poisoning
ccurs after eating unripe ackee fruit and results in vomit-
ng and life threatening hypoglycemia. Acute and chronic
yanide poisoning may occur after ingesting cassava root
roducts containing cyanogenic glycosides. Acute poison-
ng causes diarrhea, vomiting, mental confusion and death.
